世界のアミノグリコシド市場 – 業界動向と2030年までの予測

アミノグリコシド市場の分析と規模

アミノグリコシドは、生命を脅かす感染症の治療に数多くの特性を持つ、非常に強力な抗生物質です。ブドウ球菌や特定のマイコバクテリアに対する殺菌作用などの特性があるため、ヒトと動物において、さまざまな細菌感染症の治療におけるアミノグリコシドの高使用が増加しています。薬剤セグメントの中で、ゲンタマイシンが最大の市場シェアを占めており、予測期間中もその優位性を維持すると予想されています。肺、骨、関節、血液、皮膚、尿路の感染症や髄膜炎など、細菌によって引き起こされる重篤な感染症の治療に使用されます。

データブリッジ市場調査は、2023年から2030年の予測期間におけるアミノグリコシド市場の成長率を分析しています。アミノグリコシド市場の予想CAGRは、前述の予測期間において約4％になる傾向があります。市場は2022年に168万米ドルと評価され、2030年までに230万米ドルに成長すると予想されています。市場価値、成長率、市場セグメント、地理的範囲、市場プレーヤー、市場シナリオなどの市場洞察に加えて、データブリッジ市場調査チームがまとめた市場レポートには、詳細な専門家分析、患者疫学、パイプライン分析、価格分析、規制枠組みも含まれています。

アミノグリコシド市場の範囲とセグメンテーション

Market Definition

Aminoglycosides is the type of medicinal drug classified under bacteriologic gram-negative antibacterial agents and has a major function for restraining protein synthesis. Aminoglycosides consist of a part of the molecule known as amino-adjusted glycoside that is a sugar. It has been used to treat numerous bacterial infections of abdomen and urinary tract, bacteremia and endocarditis and others in humans as well as animals.

Global Aminoglycosides Market Dynamics

Drivers

• Increase in Tuberculosis Cases

The growing burden of tuberculosis is projected to drive the demand for aminoglycosides, particularly in low-income countries where the occurrence is alarmingly high and there is an urgent need for aminoglycosides. For instance, according to WHO 2021 update, a total of 1.5 million people died from tuberculosis in 2020 which includes 214,000 people with HIV. COVID-19 is the second most lethal infectious disease, while tuberculosis is the 13th most common cause of death worldwide.

• Increasing demand for Gentamicin

As per the research article published in 2020 under the title ‘Epidemiology of urological infections: a global burden’, urinary tract infections were among the most frequent infections in clinical practice. The huge burden of urinary tract infections is projected to increase the use of Gentamicin over the forecast period. Gentamicin forms the first line of treatment for several diseases. The usage of Gentamicin is predominantly high in developing regions where it is cost-effective and productive drug for several infectious diseases.

Opportunities

• Rising Adoption Of Injectable and Oral Drugs

Injectable administration is accounted for the largest share. This route is recommended for human medical usage as it provides the optimum mode of drug action mechanism through intravenous or intramuscular route for treatment. Oral use of aminoglycoside antibiotics is generally for bowel surgery to prevent severe infection at the time of surgery. Thus, this feasible route of administration increases the market share.

• Increasing Launch of New Drugs

The rising launch of several new drugs used for the treatment of bacterial infections create opportunities for the market growth. For instance, in November 2020, Huvepharma Inc. launched AVERT NE, a novel new vaccination designed to help manage necrotic enteritis caused by Clostridium perfringens Type A. Curtiss Healthcare, Inc.'s exclusive and proprietary transgenic attenuated Salmonella vaccine (RASV) technology is used as the delivery platform for AvertNE to produce an autoimmune reaction and prevent hens from necrotic enteritis.

 Restraints/Challenges

• Side Effects of Chemotherapy

Several toxic effects associated with these drugs, such as muscle twitching, seizure, and irreversible hearing loss, are responsible for restrictive growth in this industry.

• Long Approval Delays of Drugs

Short provision of quality assured active pharmaceutical ingredient and WHO-GMP compliant product for capreomycin and kanamycin acts as a primary factor which leads in failure of pre-qualification of these drug thus limiting sector growth in more developed countries.

This aminoglycosides market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the aminoglycosides market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Aminoglycosides Market

The COVID-19 outbreak significantly impacted the healthcare sector. According to the article published in 2021 under the title ‘Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents’, aminoglycosides were likely to be used as a base to create powerful COVID-19 medicinal compounds. According to a study published in August 2020 titled ‘Studies highlight the dynamic impact of COVID-19 on antibiotic use’, more than 1,700 hospitalized COVID-19 patients were treated at 38 Michigan hospitals in the U.S. from March 13, 2020, to June 18, 2020, many of them received early antibiotic therapy, with antibiotic use as high as 84% in some hospitals, that showed a positive impact on the market growth. Henceforth, as per the factors mentioned above, COVID-19 significantly impacted the market.

Recent Developments

• In March 2022, Padagis received the U.S. FDA approval for its AB-rated generic version of Tobradex Ophthalmic Suspension. The solution contains active ingredients such as tobramycin and dexamethasone. Tobradex Ophthalmic Suspension is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists.

Global Aminoglycosides Market Scope

The aminoglycosides market is segmented on the basis of drug, application, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug

• Neomycin
• Gentamicin
• Kanamycin
• Other

Application

• Veterinary
• Skin Infection
• Respiratory Diseases
• UTI and Pelvic Diseases
• Other Diseases

Route of Administration

• Injectable
• Topic
• Oral
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Aminoglycosides Market Regional Analysis/Insights

The aminoglycosides market is analyzed and market size insights and trends are provided by drug, application, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the aminoglycosides market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific has been witnessing positive growth for the aminoglycosides market throughout the forecasted period due to increased new research and developments on aminoglycosides markets.

North America dominates the market due to the presence of key manufacturers of the product is high and, increasing research and development activities, healthcare expenditure.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Global Aminoglycosides Market Share Analysis

アミノグリコシド市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、生み出される収益、市場の可能性、研究開発への投資、新しい市場への取り組み、世界的なプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性などがあります。提供されている上記のデータ ポイントは、アミノグリコシド市場に関連する会社の焦点にのみ関連しています。

アミノグリコシド市場で活動している主要企業は次のとおりです。

• クレモイントファーマ株式会社（インド）
• HuvePharma（ブルガリア）
• メディソンファーマ（インド）
• メディコ レメディーズ リミテッド (インド)
• ゾエティス（米国）
• ファイザー社（米国）
• アストラゼネカ（英国）
• アッヴィ社（米国）
• テバ製薬工業（イスラエル）

SKU-57138